GH-supporting peptides (Sermorelin, CJC/Ipamorelin, Tesamorelin) start showing visible body-composition shifts: lower visceral fat, better lean mass retention, deeper sleep
Both are manufactured by Novo Nordisk and available through standard pharmacy channels with a prescription
GLP-1 analogue liraglutide attenuates mutant huntingtin-induced neurotoxicity by restoration of neuronal insulin signaling
Both medications share similar side effect profiles primarily gastrointestinal effects like nausea, diarrhea, and constipation during dose escalation
Together, the five products form a practical system around the areas that can become more difficult when appetite and food intake are reduced: protein, lean muscle, energy, hydration, digestion, and daily micronutrition